THE DEPARTMENT HAS THREE DIVISIONS
DIVISION OF NEUROPHARMACOLOGY
The Division of Neuropharmacology emphasizes studies on the adaptive responses of the nervous system, behavioral responses to chronic and aversive stresses or chronic drug exposures, and to the amelioration of neural injuries caused by traumatic brain injury. Accurate study design, implementation and interpretation of behavioral pharmacology studies are of fundamental importance in drug development and determining disease pathophysiology.
Faculty: Dr. Caroline Browne, Dr. Brian Cox, Dr. Ying-Hong Feng, Dr. Irwin Lucki, Dr. Fereshteh Nugent, Dr. Aviva Symes
DIVISION OF MOLECULAR PHARMACOLOGY
The Division of Molecular Pharmacology addresses critical questions in immunopharmacology, cancer pharmacology, and the role of protein aggregation in neurological and other disorders. These studies are focused on defining genetic and biochemical mechanisms of normal and altered signal transduction pathways in yeast, rodent, and human cell systems, with the goal of developing new, targeted therapeutics.
Faculty: Dr. Regina Day, Dr. Ying-Hong Feng, Dr.Robert Kortum, Dr. Sergey Iordanskiy, Dr. Andrew Snow, Dr. Aviva Symes
DIVISION OF RADIATION COUNTERMEASURES
The Division of Radiation Countermeasures is concerned with understanding the consequences of radiation injury in order to develop drugs to protect the population in the event of high dose radiation exposure. These include radioprotectants that can be given to protect people from an imminent radiation exposure and radiation mitigants as therapeutics to treat acute radiation sickness and long term consequences of high dose radiation exposure.
Faculty: Dr. Catherine Davis-Takacs, Dr. Regina Day, Dr. Sergey Iordanskiy, Dr. Vijay K. Singh